ArticleCities (London, England)2022
Government dissemination of epidemic information as a policy instrument during COVID-19 pandemic: Evidence from Chinese cities.
Article in Cities (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The ongoing impact of policy documents on the pandemic based on the framework of the "4Rs" theory and policy tools: in China.BMC public health · 2025Article
- From Black Death to COVID-19: Lessons Learned from the Past Pandemics.Le infezioni in medicina · 2025Article
- Spatiotemporal heterogeneity of the association between socioeconomic development and health policy attention: a geographically and temporally weighted regression modeling study in China.Frontiers in public health · 2024Article
- The relationship between young college students' recognition of national COVID-19 crisis governance capabilities and the improvement of national identity: the mediating role of online participation in public health critical events.Frontiers in public health · 2024Article
- Analyzing the Characteristics of Policies and Political Institutions for the Prevention and Control Governance of the COVID-19 Pandemic: Evidence from China.International journal of environmental research and public health · 2022Article
- The impacts of COVID-19 on China insurance industry-An empirical analysis based on event study.Frontiers in public health · 2022Article
- The Impact of China's Paired Assistance Policy on the COVID-19 Crisis-An Empirical Case Study of Hubei Province.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 has given rise to a surge in the number of policy instruments used to deal with the pandemic at different levels of governments globally. While much attention has been placed on travel bans, lockdown, social distancing, and economic stimulus packages, government dissemination of epidemic information as a policy instrument has received less attention. Based on 14,637 news items collected from the portals of 79 municipal governments in China, this study aims to 1) conduct a content analysis of news items and construct three key attributes of governments' practices of epidemic information dissemination, namely, comprehensiveness, responsiveness, and the protection of privacy, and 2) study the patterns and determinants of the dissemination of epidemic information. Our results show that these cities vary substantially in how they disseminate statistical data and information on individual cases of COVID-19 infections within their localities, which are shaped by government performance in open data, severity of the pandemic, cities' administrative level, population, and health sector capacities. The findings generate theoretical and policy implications for government dissemination of epidemic information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.